211 related articles for article (PubMed ID: 8579890)
1. Bone and cancer: pathophysiology and treatment of metastases.
Kanis JA
Bone; 1995 Aug; 17(2 Suppl):101S-105S. PubMed ID: 8579890
[TBL] [Abstract][Full Text] [Related]
2. Rationale for the use of bisphosphonates in breast cancer.
Kanis JA
Acta Oncol; 1996; 35 Suppl 5():61-7. PubMed ID: 9142969
[TBL] [Abstract][Full Text] [Related]
3. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
[TBL] [Abstract][Full Text] [Related]
4. [Osteolytic metastases of breast cancer and biphosphonates].
Lortholary A; Alleaume C; Pein F; Larra F
Rev Med Interne; 1992; 13(3):238-42. PubMed ID: 1410908
[TBL] [Abstract][Full Text] [Related]
5. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S
Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials in metastatic breast cancer to bone: past--present--future.
Body JJ
Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
[TBL] [Abstract][Full Text] [Related]
8. Should bisphosphonates be standard therapy for bone pain?
Paterson AH
Support Care Cancer; 1997 May; 5(3):200-4. PubMed ID: 9176965
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates for metastatic bone pain.
Body JJ
Support Care Cancer; 1999 Jan; 7(1):1-3. PubMed ID: 9926966
[No Abstract] [Full Text] [Related]
10. Use of bisphosphonates in cancer patients.
Body JJ; Coleman RE; Piccart M
Cancer Treat Rev; 1996 Jul; 22(4):265-87. PubMed ID: 9025784
[No Abstract] [Full Text] [Related]
11. [Bisphosphonates and bone metastases].
Lortholary A; Jadaud E; Berthaud P
Bull Cancer; 1999 Sep; 86(9):732-8. PubMed ID: 10519966
[TBL] [Abstract][Full Text] [Related]
12. [Biosphonates in oncology].
Paule B; Clerc D; Brion N
Presse Med; 2000 Apr; 29(13):723-9. PubMed ID: 10797827
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates and breast carcinoma.
Lipton A
Cancer; 1997 Oct; 80(8 Suppl):1668-73. PubMed ID: 9362434
[TBL] [Abstract][Full Text] [Related]
14. Treatment of metastatic bone disease in breast cancer: bisphosphonates.
Diel IJ; Solomayer EF; Bastert G
Clin Breast Cancer; 2000 Apr; 1(1):43-51. PubMed ID: 11899389
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates for breast cancer.
Pavlakis N; Stockler M
Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
[TBL] [Abstract][Full Text] [Related]
16. Bone metastases and tumor-induced hypercalcemia.
Body JJ
Curr Opin Oncol; 1992 Aug; 4(4):624-31. PubMed ID: 1511019
[TBL] [Abstract][Full Text] [Related]
17. Treatment of skeletal disease in breast cancer with clodronate.
Paterson AH; Ernst DS; Powles TJ; Ashley S; McCloskey EV; Kanis JA
Bone; 1991; 12 Suppl 1():S25-30. PubMed ID: 1720012
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates in multiple myeloma.
Kanis JA; McCloskey EV
Cancer; 2000 Jun; 88(12 Suppl):3022-32. PubMed ID: 10898347
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates in the treatment of skeletal metastases.
Conte P; Coleman R
Semin Oncol; 2004 Oct; 31(5 Suppl 10):59-63. PubMed ID: 15490377
[TBL] [Abstract][Full Text] [Related]
20. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
Purohit OP; Radstone CR; Anthony C; Kanis JA; Coleman RE
Br J Cancer; 1995 Nov; 72(5):1289-93. PubMed ID: 7577484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
